Literature DB >> 9658144

Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.

M Tsuji1, C C Bergmann, Y Takita-Sonoda, K Murata, E G Rodrigues, R S Nussenzweig, F Zavala.   

Abstract

Subcutaneous administration in mice of recombinant Sindbis viruses expressing a class I major histocompatibility complex-restricted 9-mer epitope of the Plasmodium yoelii circumsporozoite protein or the nucleoprotein of influenza virus induces a large epitope-specific CD8(+) T-cell response. This immunization also elicits a high degree of protection against infection with malaria or influenza A virus.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9658144      PMCID： PMC109904     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  24 in total

1.  Infectious enveloped RNA virus antigenic chimeras.

Authors:  S D London; A L Schmaljohn; J M Dalrymple; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL.

Authors:  D H Busch; E G Pamer
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

3.  Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis.

Authors:  M W LaStarza; J A Lemm; C M Rice
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.

Authors:  A Endo; S Itamura; H Iinuma; S Funahashi; H Shida; F Koide; K Nerome; A Oya
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

5.  Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.

Authors:  J P Tite; C Hughes-Jenkins; D O'Callaghan; G Dougan; S M Russell; X M Gao; F Y Liew
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

6.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

Authors:  S Li; M Rodrigues; D Rodriguez; J R Rodriguez; M Esteban; P Palese; R S Nussenzweig; F Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.

Authors:  C S Hahn; Y S Hahn; T J Braciale; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.

Authors:  M E Andrew; B E Coupar; D B Boyle; G L Ada
Journal:  Scand J Immunol       Date:  1987-01       Impact factor: 3.487

10.  Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

Authors:  M Rodrigues; S Li; K Murata; D Rodriguez; J R Rodriguez; I Bacik; J R Bennink; J W Yewdell; A Garcia-Sastre; R S Nussenzweig
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422
View more
  29 in total

1.  Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

Authors:  O Bruña-Romero; G González-Aseguinolaza; J C Hafalla; M Tsuji; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity.

Authors:  Tomer Granot; Yoshihide Yamanashi; Daniel Meruelo
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

3.  Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface.

Authors:  Myrna C Bonaldo; Richard C Garratt; Renato S Marchevsky; Evandro S F Coutinho; Alfredo V Jabor; Luís F C Almeida; Anna M Y Yamamura; Adriana S Duarte; Prisciliana J Oliveira; Jackeline O P Lizeu; Luiz A B Camacho; Marcos S Freire; Ricardo Galler
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.

Authors:  Takayuki Shiratsuchi; Urvashi Rai; Izumi Kaneko; Min Zhang; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Vaccine       Date:  2017-10-28       Impact factor: 3.641

5.  Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.

Authors:  O J A E Ophorst; K Radosević; M J E Havenga; M G Pau; L Holterman; B Berkhout; J Goudsmit; M Tsuji
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

7.  Influenza A virus-specific CD8 T-cell responses: from induction to function.

Authors:  Mr Olson; Be Russ; Pc Doherty; Sj Turner; J Stambas
Journal:  Future Virol       Date:  2010-03-01       Impact factor: 1.831

8.  Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs.

Authors:  Eugenio J Abente; Daniela S Rajao; Phillip C Gauger; Amy L Vincent
Journal:  Vaccine       Date:  2019-02-02       Impact factor: 3.641

9.  Selection of functional 5' cis-acting elements promoting efficient sindbis virus genome replication.

Authors:  Rodion Gorchakov; Richard Hardy; Charles M Rice; Ilya Frolov
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 10.  Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.

Authors:  Michael Glen Overstreet; Ian Andrew Cockburn; Yun-Chi Chen; Fidel Zavala
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.